AnaptysBio, Inc.
DE ˙ DB ˙ US0327241065
44,87 € ↑0,64 (1,45%)
2026-06-04
AKTIENPREIS
SecurityDE:AN6 / AnaptysBio, Inc.
InstitutionFmr Llc
Latest Disclosed Ownership254,211 shares
Ownership 0.90%
Fmr Llc ownership in AN6 / AnaptysBio, Inc.

2025-06-06 - Fmr Llc has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 254,211 shares of AnaptysBio, Inc. (DE:AN6). This represents 0.9 percent ownership of the company. In their previous filing dated 2025-05-12 , Fmr Llc had reported owning 1,905,153 shares, indicating a decrease of -86.66 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2025-06-06 2025-06-06 13G/A 1,905,153 254,211 -86.66 0.90 -85.48
2025-05-12 2025-05-12 13G/A 2,870,618 1,905,153 -33.63 6.20 -40.99
2024-07-10 2024-07-10 13G 177,739 2,870,618 1,515.07 10.51 1,504.12
2019-12-10 2019-12-10 13G/A 4,012,735 177,739 -95.57 0.66 -95.63
2019-02-13 2019-02-13 13G/A 3,324,468 4,012,735 20.70 15.00 6.01
2018-02-13 2018-02-13 13G/A 2,192,030 3,324,468 51.66 14.15 31.30
2017-10-10 2017-10-10 13G 2,192,030 10.78

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ANAPTYSBIO COM 032724106 472,704 445,596 1,643.78 26,216 1,895.13 0.0003
2026-02-17 2025-12-31 13F ANAPTYSBIO COM 032724106 27,108 -26,054 -49.01 1,314 -19.24 0.0001
2025-11-13 2025-09-30 13F ANAPTYSBIO COM 032724106 53,162 -18,957 -26.29 1,628 1.62 0.0001
2025-08-14 2025-06-30 13F ANAPTYSBIO COM 032724106 72,119 -1,833,035 -96.21 1,601 -95.48 0.0001
2025-05-12 2025-03-31 13F ANAPTYSBIO COM 032724106 1,905,154 -1,125,082 -37.13 35,417 -11.72 0.0023
2025-02-13 2024-12-31 13F ANAPTYSBIO COM 032724106 3,030,236 -278,939 -8.43 40,120 -63.81 0.0024
2024-11-13 2024-09-30 13F ANAPTYSBIO COM 032724106 3,309,175 438,557 15.28 110,857 54.10 0.0067
2024-08-13 2024-06-30 13F ANAPTYSBIO COM 032724106 2,870,618 2,729,872 1,939.57 71,938 2,170.02 0.0046
2024-05-13 2024-03-31 13F ANAPTYSBIO COM 032724106 140,746 -61,965 -30.57 3,170 -27.02 0.0002
2024-02-13 2023-12-31 13F ANAPTYSBIO COM 032724106 202,711 -64,904 -24.25 4,342 -9.65 0.0003
2023-11-13 2023-09-30 13F ANAPTYSBIO COM 032724106 267,615 -25,951 -8.84 4,806 -19.51 0.0004
2023-08-11 2023-06-30 13F ANAPTYSBIO COM 032724106 293,566 1,449 0.50 5,971 -6.06 0.0005
2023-08-11 2023-03-31 13F/A-1 ANAPTYSBIO COM 032724106 292,117 1,201 0.41 6,356 -29.50 0.0006
2023-05-11 2023-03-31 13F ANAPTYSBIO COM 032724106 292,117 1,201 6,356 0.0006
2023-02-13 2022-12-31 13F ANAPTYSBIO COM 032724106 290,916 186,831 179.50 9,015 239.42 0.0009
2022-11-10 2022-09-30 13F ANAPTYSBIO COM 032724106 104,085 -26,807 -20.48 2,656 -0.04 0.0003
2022-08-12 2022-06-30 13F ANAPTYSBIO COM 032724106 130,892 -48,029 -26.84 2,657 -39.97 0.0003
2022-05-13 2022-03-31 13F ANAPTYSBIO COM 032724106 178,921 156,960 714.72 4,426 480.08 0.0004
2022-02-14 2021-12-31 13F ANAPTYSBIO COM 032724106 21,961 21,563 5,417.84 763 6,836.36 0.0001
2022-02-14 2021-09-30 13F/A-1 ANAPTYSBIO COM 032724106 398 165 70.82 11 83.33 0.0000
2021-11-15 2021-09-30 13F ANAPTYSBIO COM 032724106 398 165 11 0.0000
2021-08-13 2021-06-30 13F ANAPTYSBIO COM 032724106 233 -7 -2.92 6 20.00 0.0000
2021-05-14 2021-03-31 13F ANAPTYSBIO COM 032724106 240 -213,170 -99.89 5 -99.89 0.0000
2021-02-08 2020-12-31 13F ANAPTYSBIO COM 032724106 213,410 -104 -0.05 4,588 45.65 0.0004
2020-11-13 2020-09-30 13F ANAPTYSBIO COM 032724106 213,514 -74,552 -25.88 3,150 -51.05 0.0003
2020-08-24 2020-06-30 13F/A-1 ANAPTYSBIO COM 032724106 288,066 90,838 46.06 6,435 130.89 0.0007
2020-08-13 2020-06-30 13F ANAPTYSBIO COM 032724106 288,066 90,838 6,435 158.0891
2020-05-14 2020-03-31 13F ANAPTYSBIO COM 032724106 197,228 20,915 11.86 2,787 -2.76 0.0004
2020-02-07 2019-12-31 13F ANAPTYSBIO COM 032724106 176,313 -3,880,826 -95.65 2,866 -97.98 0.0003
2019-11-13 2019-09-30 13F ANAPTYSBIO COM 032724106 4,057,139 3,581 0.09 141,959 -37.93 0.0170
2019-08-13 2019-06-30 13F ANAPTYSBIO COM 032724106 4,053,558 5,571 0.14 228,702 -22.66 0.0267
2019-05-13 2019-03-31 13F ANAPTYSBIO COM 032724106 4,047,987 35,252 0.88 295,705 15.52 0.0354
2019-02-13 2018-12-31 13F ANAPTYSBIO COM 032724106 4,012,735 77,268 1.96 255,973 -34.81 0.0351
2018-11-09 2018-09-30 13F ANAPTYSBIO COM 032724106 3,935,467 410,918 11.66 392,642 56.82 0.0442
2018-08-10 2018-06-30 13F ANAPTYSBIO COM 032724106 3,524,549 -46,051 -1.29 250,384 -32.63 0.0296
2018-05-14 2018-03-31 13F ANAPTYSBIO COM 032724106 3,570,600 246,647 7.42 371,628 11.00 0.0441
2018-02-12 2017-12-31 13F ANAPTYSBIO COM 032724106 3,323,953 1,131,923 51.64 334,789 336.99 0.0392
2017-11-13 2017-09-30 13F ANAPTYSBIO COM 032724106 2,192,030 2,192,030 76,612 0.0093
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.